Downes MR - Search Results

1

A novel association of gastric ischaemia and aortic coarctation.

Turowski C, Downes MR, Devaney DM, Donoghue V, Gillick J. Turowski C, et al. Among authors: downes mr. Pediatr Surg Int. 2010 Aug;26(8):843-6. doi: 10.1007/s00383-010-2631-4. Epub 2010 Jun 8. Pediatr Surg Int. 2010. PMID: 20532527

2

Gastroesophageal Mucosal Injury after Cholecystectomy: An Indication for Surveillance?

Shah Gilani SN, Bass GA, Kharytaniuk N, Downes MR, Caffrey EF, Tobbia I, Walsh TN. Shah Gilani SN, et al. Among authors: downes mr. J Am Coll Surg. 2017 Mar;224(3):319-326. doi: 10.1016/j.jamcollsurg.2016.12.003. Epub 2016 Dec 18. J Am Coll Surg. 2017. PMID: 27993699

3

Urinary markers for prostate cancer.

Downes MR, Byrne JC, Pennington SR, Dunn MJ, Fitzpatrick JM, Watson RW. Downes MR, et al. BJU Int. 2007 Feb;99(2):263-8. doi: 10.1111/j.1464-410X.2006.06610.x. Epub 2006 Dec 1. BJU Int. 2007. PMID: 17092277 Review.

4

Detecting soluble clusterin in in-vitro and in-vivo models of prostate cancer.

Girard FP, Byrne J, Downes M, Fanning D, Desgrandchamps F, Fitzpatrick JM, Watson RW. Girard FP, et al. Neoplasma. 2010;57(5):488-93. doi: 10.4149/neo_2010_05_488. Neoplasma. 2010. PMID: 20568904

5

Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review.

Downes MR, Byrne JC, Dunn MJ, Fitzpatrick JM, Watson RW, Pennington SR. Downes MR, et al. Biomarkers. 2006 Sep-Oct;11(5):406-16. doi: 10.1080/13547500600799821. Biomarkers. 2006. PMID: 16966158 Review.

6

2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer.

Byrne JC, Downes MR, O'Donoghue N, O'Keane C, O'Neill A, Fan Y, Fitzpatrick JM, Dunn M, Watson RW. Byrne JC, et al. Among authors: downes mr. J Proteome Res. 2009 Feb;8(2):942-57. doi: 10.1021/pr800570s. J Proteome Res. 2009. PMID: 19093873

7

Analysis of trends and seasonal variation in primary cutaneous melanoma: an Irish study.

Downes MR, Fan Y, Murphy G, Gulmann C. Downes MR, et al. Clin Exp Dermatol. 2011 Jun;36(4):374-7. doi: 10.1111/j.1365-2230.2010.03952.x. Clin Exp Dermatol. 2011. PMID: 21251243

8

Fasting status as a consideration for human serum collection and preparation prior to depletion and analysis.

Byrne JC, Downes MR, O'Donoghue N, Fitzpatrick JM, Dunn MJ, Watson RW. Byrne JC, et al. Among authors: downes mr. Electrophoresis. 2008 Jul;29(14):3055-9. doi: 10.1002/elps.200700933. Electrophoresis. 2008. PMID: 18551713

9

p53 immunohistochemistry in high-grade urothelial carcinoma of the bladder is prognostically significant.

Hodgson A, Xu B, Downes MR. Hodgson A, et al. Among authors: downes mr. Histopathology. 2017 Aug;71(2):296-304. doi: 10.1111/his.13225. Epub 2017 May 22. Histopathology. 2017. PMID: 28342221

10

Basal-subtype bladder tumours show a 'hot' immunophenotype.

Hodgson A, Liu SK, Vesprini D, Xu B, Downes MR. Hodgson A, et al. Among authors: downes mr. Histopathology. 2018 Nov;73(5):748-757. doi: 10.1111/his.13696. Epub 2018 Aug 14. Histopathology. 2018. PMID: 29947424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters